Aboriginal and Torres Strait Islander peoples' perspectives on community pharmacists prescribing: a co-designed study protocol
Australian Health Review · 2024
DOI: 10.1071/ah24110 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Australian Health Review, 2024. Verfasst von Cara Cross und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of New South Wales, NSW, Australia. Hauptthemen laut MEDLINE: Australian Aboriginal and Torres Strait Islander Peoples, Pharmacists. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: New South Wales Government.
Abstract (Originalsprache)
Background
In Australia, medications can be prescribed by medical practitioners, dentists, nurses, and dispensed by pharmacists. Until recently, pharmacists have been limited to prescribing Schedule 2 and 3 medications, and optometrists, podiatrists, and nurse practitioners can prescribe medications under their scope of practice in some areas of Australia. Recently, the New South Wales (NSW) Government initiated a trial where approved pharmacists in NSW and Australian Capital Territory have an expanded scope of practice to prescribe further medications for urinary tract infections, dermatology conditions (mild to moderate atopic dermatitis, herpes zoster (shingles), impetigo, and mild plaque psoriasis), and resupply of contraceptives. This protocol is for a sub-study of the larger research trial and will explore the perspectives of Aboriginal and Torres Strait Islander peoples and communities including clinicians, healthcare services, and community members about the expanded scope of pharmacists’ practice. Methods and analysis Yarning circles (group) and individual yarns (semi-structured interviews) will be conducted with leaders, clinicians working with Aboriginal and Torres Strait Islander peoples (general practitioners, nurses, Aboriginal health workers, community pharmacists), Aboriginal Elders, and community members to understand perspectives of the risks, benefits, opportunities, and issues associated with pharmacists prescribing for these specific conditions. Ethics approval was obtained through the Aboriginal Health and Medical Research Council of NSW.
Conclusion
The findings of this sub-study will clarify Aboriginal and Torres Strait Islander peoples’ unique perspectives, including perception of risks and opportunities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of New South Wales, NSW, Australia.
- Djurali Centre for Aboriginal and Torres Strait Islander Health Research and Education, Heart Research Institute, 7 Eliza Street, Newtown, NSW 2042, Australia.
- Brewarrina Aboriginal Medical Service, Brewarrina, NSW, Australia.
- Armajun Aboriginal Health Service, Inverell, NSW, Australia.
- Pharmaceutical Care Research Group, Faculty of Pharmacy, University of Granada, Spain.
- School of Biomedical Sciences and Pharmacy, The University of Newcastle, NSW, Australia.
Förderung
- New South Wales Government
Zitieren
APA
Cross, C., Christie, V., Holt, L., Rambaldini, B., Ward, K., Skinner, J., Henson, C., McCowen, D., Benrimoj, S. C., Dineen-Griffin, S., & Gwynne, K. (2024). Aboriginal and Torres Strait Islander peoples' perspectives on community pharmacists prescribing: a co-designed study protocol. Australian Health Review. https://doi.org/10.1071/ah24110
Vancouver
Cross C, Christie V, Holt L, Rambaldini B, Ward K, Skinner J, et al. Aboriginal and Torres Strait Islander peoples' perspectives on community pharmacists prescribing: a co-designed study protocol. Australian Health Review. 2024. doi:10.1071/ah24110
BibTeX
@article{Cross2024,
author = {Cross, Cara and Christie, Vita and Holt, Leanne and Rambaldini, Boe and Ward, Katrina and Skinner, John and Henson, Connie and McCowen, Debbie and Benrimoj, Shalom Charlie and Dineen-Griffin, Sarah and Gwynne, Kylie},
title = {Aboriginal and Torres Strait Islander peoples' perspectives on community pharmacists prescribing: a co-designed study protocol},
journal = {Australian Health Review},
year = {2024},
doi = {10.1071/ah24110}
}
EUVIMED